Gene · 3488
Papers3,939
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,939
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated proteome sequencing, bulk RNA sequencing and single-cell RNA sequencing to identify potential biomarkers in different grades of intervertebral disc degeneration. | Front Cell Dev Biol | 2023 | 37009470 | PubTator, text mining | PubMed |
| Short stature related to Growth Hormone Insensitivity (GHI) in childhood. | Front Endocrinol (Lausanne) | 2023 | 37008935 | PubTator, text mining | PubMed |
| Expression patterns of eight RNA-modified regulators correlating with immune infiltrates during the progression of osteoarthritis. | Front Immunol | 2023 | 37006267 | PubTator, text mining | PubMed |
| Molecules promoting circulating clusters of cancer cells suggest novel therapeutic targets for treatment of metastatic cancers. | Front Immunol | 2023 | 37006265 | PubTator, text mining | PubMed |
| Metabolic reprogramming in cancer: Mechanisms and therapeutics. | MedComm (2020) | 2023 | 36994237 | PubTator, text mining | PubMed |
| Esm-1 mediates transcriptional polarization associated with diabetic kidney disease. | bioRxiv | 2023 | 36993439 | PubTator, text mining | PubMed |
| Digital spatial profiling of human parathyroid tumors reveals cellular and molecular alterations linked to vitamin D deficiency. | PNAS Nexus | 2023 | 36992820 | PubTator, text mining | PubMed |
| TMED3 promotes the development of malignant melanoma by targeting CDCA8 and regulating PI3K/Akt pathway. | Cell Biosci | 2023 | 36991473 | PubTator, text mining | PubMed |
| miR-424(322)-5p targets Ezh1 to inhibit the proliferation and differentiation of myoblasts. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 36988349 | PubTator, text mining | PubMed |
| The Exosome-Mediated PI3K/Akt/mTOR Signaling Pathway in Neurological Diseases. | Pharmaceutics | 2023 | 36986865 | PubTator, text mining | PubMed |
| Pentosan Polysulfate Affords Pleotropic Protection to Multiple Cells and Tissues. | Pharmaceuticals (Basel) | 2023 | 36986536 | PubTator, text mining | PubMed |
| Induced Coma, Death, and Organ Transplantation: A Physiologic, Genetic, and Theological Perspective. | Int J Mol Sci | 2023 | 36982814 | PubTator, text mining | PubMed |
| Drug-Induced Gingival Overgrowth-Molecular Aspects of Drug Actions. | Int J Mol Sci | 2023 | 36982523 | PubTator, text mining | PubMed |
| The Antimicrobial Peptide AMP-IBP5 Suppresses Dermatitis-like Lesions in a Mouse Model of Atopic Dermatitis through the Low-Density Lipoprotein Receptor-Related Protein-1 Receptor. | Int J Mol Sci | 2023 | 36982275 | PubTator, text mining | PubMed |
| Different Resistance Exercise Loading Paradigms Similarly Affect Skeletal Muscle Gene Expression Patterns of Myostatin-Related Targets and mTORC1 Signaling Markers. | Cells | 2023 | 36980239 | PubTator, text mining | PubMed |
| Machine Learning Model Based on Insulin Resistance Metagenes Underpins Genetic Basis of Type 2 Diabetes. | Biomolecules | 2023 | 36979367 | PubTator, text mining | PubMed |
| Signaling Pathways of the Insulin-like Growth Factor Binding Proteins. | Endocr Rev | 2023 | 36974712 | PubTator, text mining | PubMed |
| Transcriptional drifts associated with environmental changes in endothelial cells. | Elife | 2023 | 36971339 | PubTator, text mining | PubMed |
| Edaravone and mitochondrial transfer as potential therapeutics for vanishing white matter disease astrocyte dysfunction. | CNS Neurosci Ther | 2023 | 36971196 | PubTator, text mining | PubMed |
| IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1/HER2-CREB signaling axis. | Nat Commun | 2023 | 36949068 | Swiss-Prot, curated | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3488/papers?page=19